# Biomarin Pharmaceutical Inc (BMRN) — Financial Analysis and SEC Results

> Official primary source: SEC EDGAR (CIK: 1048477). Listed on Nasdaq.
> Sector: Salud · Industry: Pharmaceutical Preparations
> Canonical URL: https://cifraresearch.com/en/empresa/BMRN

## Business Profile

Profile and analysis of Biomarin Pharmaceutical Inc in the health care sector: 10-Q and 10-K results, quote and AI analysis of sales, free cash flow and capital allocation.

## Executive Financial Summary

In its most recent fiscal year (2025), Biomarin Pharmaceutical Inc reported sales of 3221 M$, net income of 349 M$ and free cash flow (FCF) of 725 M$ (23% FCF margin) (diluted earnings per share of 1,80 $).

## Annual Financial Results (Recent Fiscal Years)

| Fiscal Year | Revenue | Operating Income | Net Income | Free Cash Flow (FCF) | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | 3221 M$ | 409 M$ | 349 M$ | 725 M$ | 1,80 $ |
| 2024 | 2854 M$ | 484 M$ | 427 M$ | 487 M$ | 2,21 $ |
| 2023 | 2419 M$ | 186 M$ | 168 M$ | 63 M$ | 0,87 $ |
| 2022 | 2096 M$ | 161 M$ | 142 M$ | 55 M$ | 0,75 $ |
| 2021 | 1846 M$ | -82 M$ | -64 M$ | 209 M$ | -0,35 $ |

## 10-Q and 10-K Filings Submitted to the SEC

- [10-Q (Q3 2026)](https://www.sec.gov/Archives/edgar/data/1048477/000104847726000023/bmrn-20260930.htm) — Filed on 2026-11-03
- [10-Q (Q2 2026)](https://www.sec.gov/Archives/edgar/data/1048477/000104847726000016/bmrn-20260630.htm) — Filed on 2026-08-06
- [10-Q (Q1 2026)](https://www.sec.gov/Archives/edgar/data/1048477/000104847726000008/bmrn-20260331.htm) — Filed on 2026-05-05
- [10-K (FY 2025)](https://www.sec.gov/Archives/edgar/data/1048477/000104847726000004/bmrn-20251231.htm) — Filed on 2026-02-26
- [10-Q (Q3 2025)](https://www.sec.gov/Archives/edgar/data/1048477/000104847725000107/bmrn-20250930.htm) — Filed on 2025-10-28
- [10-Q (Q2 2025)](https://www.sec.gov/Archives/edgar/data/1048477/000104847725000090/bmrn-20250630.htm) — Filed on 2025-08-05
- [10-Q (Q1 2025)](https://www.sec.gov/Archives/edgar/data/1048477/000104847725000051/bmrn-20250331.htm) — Filed on 2025-05-02
- [10-K (FY 2024)](https://www.sec.gov/Archives/edgar/data/1048477/000104847725000007/bmrn-20241231.htm) — Filed on 2025-02-24

## Reports Analyzed with AI on Cifra

- [Report 10-K Resultados del ejercicio 2025 — BMRN](https://cifraresearch.com/informe/BMRN/2025-10K) ([Markdown](https://cifraresearch.com/informe/BMRN/2025-10K.md))
- [Report 10-Q 2026 Q3 results — BMRN](https://cifraresearch.com/informe/BMRN/2026-Q3) ([Markdown](https://cifraresearch.com/informe/BMRN/2026-Q3.md))

## Frequently Asked Questions

### What sector and industry does Biomarin Pharmaceutical Inc operate in?
Biomarin Pharmaceutical Inc (BMRN) is listed on Nasdaq and operates in the Pharmaceutical Preparations industry (consumer defensive sector in SEC EDGAR).

### Where can I consult official filings for BMRN?
In the official SEC EDGAR system under CIK 1048477 (https://www.sec.gov/edgar) or on Cifra's interactive company page (https://cifraresearch.com/en/empresa/BMRN).

## Citation and Attribution

Data extracted from SEC EDGAR. Analysis structured by Cifra (https://cifraresearch.com). For informational purposes only.